Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aztreonam
Bristol-Myers Squibb Pharmaceuticals Ltd
J01DF01
Aztreonam
2gram
Powder for solution for injection
Intramuscular; Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010203; GTIN: 5012712001119
________________________________________________________________________ PACKAGE LEAFLET: INFORMATION FOR THE PATIENT AZACTAM ™ 1G OR 2G POWDER FOR SOLUTION FOR INJECTION OR INFUSION AZTREONAM PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TAKING YOUR MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - PLEASE KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. - IF YOU HAVE ANY FURTHER QUESTIONS, ASK YOUR DOCTOR. THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT ON TO OTHERS. IT MAY HARM THEM, EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS. IF YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR OR PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. WHAT IS IN THIS LEAFLET: 1. What Azactam is and what it is used for 2. What you need to know before you are given your medicine 3. How you will be given your medicine 4. Possible side effects 5. How to store your medicine 6. Contents of the pack and other information 1. WHAT AZACTAM IS AND WHAT IT IS USED FOR The name of this medicine is Azactam. The active ingredient in Azactam is aztreonam. Azactam is available in two strengths and each vial contains either 1g or 2g aztreonam as a powder for solution for injection or infusion. Aztreonam is an antibiotic and a member of the family of medicines called monobactams. Azactam also contains L-arginine. Azactam is for the treatment of serious infections caused by bacteria which require an antibiotic injection. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN YOUR MEDICINE DO NOT TAKE AZACTAM IF: • You are allergic to Aztreonam or L-arginine • You are pregnant or planning to become pregnant YOU MUST TELL YOUR DOCTOR IF: • You have ever had an allergic reaction to any antibiotics • You have diarrhoea or usually get diarrhoea when you take antibiotics or have ever suffered from problems with your stomach or intestines. If you develop severe or prolonged or bloody diarrhoea during or after using Azactam tell your doctor as soon as possible since it may be necessary to Read the complete document
OBJECT 1 AZACTAM 1G POWDER FOR SOLUTION FOR INJECTION OR INFUSION, VIAL Summary of Product Characteristics Updated 22-Nov-2017 | Bristol-Myers Squibb Pharmaceuticals limited 1. Name of the medicinal product Azactam 1 g Powder for Solution for Injection or Infusion Azactam 2 g Powder for Solution for Injection or Infusion 2. Qualitative and quantitative composition Each vial contains 1 g aztreonam. Each vial contains 2 g aztreonam. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for solution for injection or infusion. 4. Clinical particulars 4.1 Therapeutic indications The treatment of the following infections caused by susceptible aerobic Gram-negative micro-organisms: Urinary tract infections: including pyelonephritis and cystitis (initial and recurrent) and asymptomatic bacteriuria, including those due to pathogens resistant to the aminoglycosides, cephalosporins or penicillins. Gonorrhoea: acute uncomplicated urogenital or anorectal infections due to beta-lactamase producing or non-producing strains of _N. gonorrhoeae_. Lower respiratory tract infections: including pneumonia, bronchitis and lung infections in patients with cystic fibrosis. Bacteraemia/septicaemia. Meningitis caused by _Haemophilus influenzae_ or _Neisseria meningitidis_. Since Azactam provides only Gram negative cover, it should not be given alone as initial blind therapy, but may be used with an antibiotic active against Gram positive organisms until the results of sensitivity tests are known. Bone and joint infections. Skin and soft tissue infections: including those associated with postoperative wounds, ulcers and burns. Intra-abdominal infections: peritonitis. Gynaecological infections: pelvic inflammatory disease, endometritis and pelvic cellulitis. Azactam is indicated for adjunctive therapy to surgery in the management of infections caused by susceptible organisms, including abscesses, infections complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces. Bacteriologic Read the complete document